A Self-Administered Home Flu Vaccine Is Coming—8 Things to Know About It
Next year’s flu season will have an additional option for people looking to protect themselves: a flu vaccine that can be ...
What Doctors Want You to Know About the New Home Flu Vaccine Coming Next Year
Next year’s flu season will have an additional option for people looking to protect themselves: a flu vaccine that can be ...
Pharmaceutical Technology2h
EMA CHMP recommends AstraZeneca’s Fasenra to treat EGPA
The EMA CHMP has recommended granting approval for AstraZeneca’s Fasenra for eosinophilic granulomatosis with polyangiitis ...
FDA just greenlighted an at-home flu vaccine. What the approval of a self-administered spray means for you.
FluMist has been sold at pharmacies for years, but now it will be available to use at home as early as next year.
Daily5h
Lung cancer drug: AstraZeneca India wins CDSCO nod for Durvalumab for specified additional indication
Bengaluru: AstraZeneca Pharma India Limited has received permission to import for sale and distribution of Durvalumab 120 ...
WXYZ13h
First self-administered, at-home flu vaccine receives FDA approval
There’s good news for those who are short on time when it comes to getting a flu shot. The FDA has approved the first ...
CNET15h
An At-Home Flu Vaccine? It'll Be Available Next Year
FluMist won't be available until next year, according to the website for FluMist, which is owned by AstraZeneca. Once it does ...
Pharmaceutical Technology15h
FDA approves AstraZeneca FluMist flu vaccine for self-administration
The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...
ConsumerAffairs15h
FDA approves first at-home nasal spray flu vaccine for the 2-49 age range
The Food and Drug Administration (FDA) has approved a nasal spray flu vaccine, FluMist, that consumers aged 2 to 49  will be ...
Nasal spray flu vaccine gets FDA approval for home use: ‘A good alternative’
The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult caregiver. Dr. Nicole Saphier and Dr. Marc Siegel weigh in.
At-home flu vaccine authorized by FDA
FluMist, a nasal spray vaccine, can be self-administered and is approved for two-year-olds up to 49-year-olds. It has to be ...
The American Journal of Managed Care18h
FDA Approves First Self-Administered Nasal Spray Flu Vaccine
The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered ...